Norgine

Pharmaceutical products and European commercialization partnerships for patients and healthcare systems

Rueil-Malmaison, FranceFounded 1955norgine.frWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Norgine

Norgine develops and commercializes pharmaceutical products, with therapeutic areas including gastroenterology, gynecology, hepatology, oncology, rare diseases and supportive care. It also works with partners through licensing, acquisitions and other collaboration arrangements.

The company’s stated focus is bringing products to European markets for patients and healthcare systems. Norgine SAS is headquartered in Rueil-Malmaison, France, and the group describes an integrated European infrastructure with more than 1,500 employees.

Product: Pharmaceutical products and development and commercialization partnerships across several therapeutic areas.

Public tenders won

2 tenders won since 1 Jan 2024 from 2 public buyers in France, worth €5.4M as awarded. From EU award notices (TED) that name Norgine by its registry number.

  • 24 Feb 2025 AGEPS · SPECIALITES PHARMACEUTIQUES notice
  • 16 Apr 2024 GCS GRAPS GRAND EST · Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est - relance de lots · €5.4M notice

Open tenders like these →

Jobs at Norgine

No open positions listed right now.

More biotech & pharma companies

  • Novalix

    Preclinical drug discovery services for biotechnology and pharmaceutical companies
    Strasbourg, FranceBiotech & pharmaFounded 20022 open jobs
    New on Evolc
  • Novaptech

    Custom aptamer development, assays and biosensors for biotechnology, pharmaceutical, academic and agri-food organizations
    Gradignan, FranceBiotech & pharmaFounded 2016
    New on Evolc
  • Novo Nordisk

    Pharmaceutical company making diabetes, obesity and rare disease medicines and injection pens for patients in France
    Puteaux, FranceBiotech & pharmaFounded 2003
    New on Evolc
  • Oddifact

    AI platform that prepares orphan drug programs for rare diseases and hands them to pharma partners for development
    Paris, FranceBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • OGD2 Pharma

    Biotherapy developer targeting the tumour-restricted OAcGD2 antigen for high-risk neuroblastoma treatment
    Nantes, FranceBiotech & pharmaFounded 2014
    New on Evolc
  • Oncodesign Services

    Preclinical CRO running in vivo pharmacology, imaging and radiopharmaceutical studies for biotech and pharma sponsors
    Dijon, FranceBiotech & pharmaFounded 19952 open jobs
    New on EvolcRemote-friendly

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Bootstrap
  • Google Analytics 4
  • Google Universal Analytics
  • WordPress
  • jQuery
  • nginx